Asa Waldstein

This video exemplifies the essence of my professional world. I share this in loving memory of my father @awaldstein who was integral in helping me think creatively about business and success. @AsaWaldstein #RegulatoryCompliance #MarketingCompliance #Supplements #HempIndustry

Asa's Monthly Regulatory Update (June) 📑 - mailchi.mp/asawaldstein/a…

Asa's Monthly Regulatory Update (March) 📑 - mailchi.mp/asawaldstein/a…

Exciting Partnership Annoucement: Apex Compliance & Informa, SENPA, and NASC - mailchi.mp/asawaldstein/a…

Last panel of the @OrgNatHealth conference! Moderator @PitchAmy @INICIVOX leads a discussion on product integrity🔎 Erin Taraborrelli @Nutrasource_NDI David Trosin @NSF_Intl Sandra Lee @NJ_Labs Deleo de Leonardis Purity-IQ @AsaWaldstein Apex Compliance #ONHealth2025

@asawaldstein/video/7461730012224294186?is_from_webapp=1&sender_device=pc&web_id=7456670772447217157" target="_blank" rel="nofollow noopener">tiktok.com/@asawaldstein/…

Making a “Certified Non-Toxic” claim on a mouthwash triggered a competitor challenge. According to the National Advertising Division (NAD) comments, the substantiation provided by the company was not sufficient to support the claim. asawaldstein.com/warning-letter…

Marketing GLP-1 Products? Avoid These Common Pitfalls!

Asa's Monthly Regulatory Update (September) 📑 - mailchi.mp/asawaldstein/a…

Marketing Claims Turn Cosmetic Into a Drug - mailchi.mp/asawaldstein/y…

This is a cautionary tale of how quality control, food safety oversight, and sanitation, even at one of the world's largest companies, can go wrong. Read the full post here. asawaldstein.com/warning-letter… #WarningLetterWednesday #Salmonella #FoodSafety

Are clinical studies really needed on finished dietary supplements? Here, I review a recent National Advertising Division (NAD) case on the topic. Full post here. asawaldstein.com/warning-letter… #WarningLetterWednesday #ClinicallyProven

I often see companies with compliant labels but have blogs on their websites filled with disease claims. In this post, we'll help demystify when "educational" blogs become marketing. Learn more here. asawaldstein.com/warning-letter… #WarningLetterWednesday #Blog #Supplement

This company received a warning letter for selling tianeptine—a substance deemed dangerous and inappropriate for dietary supplements according to FDA. Read the full post here. asawaldstein.com/warning-letter… #WarningLetterWednesday #Tianeptine #RegulatoryCompliance

Here, we learn more about when material connection is needed and what constitutes disclosure, especially when children’s advertising is involved. Full post here 👉👉asawaldstein.com/warning-letter… #WarningLetterWednesday #InfluencerMarketing #VladAndNikki

This NAD case shows that making “clinically proven” claims attracts the highest level of scrutiny. Read the full post here. asawaldstein.com/warning-letter… #WarningLetterWednesday #ClinicallyProven #Puffery

This NAD case is a good reminder of the importance of influencers properly disclosing material connections in the same manner that endorsement is made. Read the full post here. asawaldstein.com/warning-letter… #WarningLetterWednesday #NAD #Influencer

I explore these arthritis warning letters, look at common trends, and share key takeaways. Read the full post here. asawaldstein.com/warning-letter… #WarningLetterWednesday #Arthritis #Supplements #RegulatoryCompliance

Based on website claims FDA concluded the product was an analgesic drug. Full warning letter here. asawaldstein.com/warning-letter… #WarningLetterWednesday #Magnesium #DrugClaim

Asa's Monthly Regulatory Update (April) 📑 - mailchi.mp/asawaldstein/a…

#RegulatoryEducationSeries naturalproductsinsider.com/supplement-reg…